We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+12.65%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$5.78B
AUM Growth
+$835M
Cap. Flow
+$277M
Cap. Flow %
4.8%
Top 10 Hldgs %
26.71%
Holding
195
New
15
Increased
119
Reduced
40
Closed
13

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$20.6M
2
WBT
Welbilt, Inc.
WBT
+$19.1M
3
MRK icon
Merck
MRK
+$18.9M
4
PGR icon
Progressive
PGR
+$18.5M
5
COO icon
Cooper Companies
COO
+$16.9M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 19.84%
2 Healthcare 19.16%
3 Technology 18.19%
4 Financials 13.19%
5 Industrials 11.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SSTI icon
151
SoundThinking
SSTI
$106M
$5.74M 0.1%
225,000
+125,000
+125% +$2.78M
ILMN icon
152
Illumina
ILMN
$29.1B
$5.6M 0.1%
17,357
-10,280
-37% -$3.12M
BE icon
153
Bloom Energy
BE
$69.9B
$5.57M 0.1%
745,509
-572,122
-43% -$2.77M
DMRC icon
154
Digimarc Corp
DMRC
$167M
$5.37M 0.09%
160,000
+60,000
+60% +$2.15M
DXCM icon
155
DexCom
DXCM
$34.3B
$5.03M 0.09%
92,000
+32,000
+53% +$1.52M
LOOP icon
156
Loop Industries
LOOP
$32.2M
$4.58M 0.08%
462,307
+55,723
+14% +$600K
TSLA icon
157
Tesla
TSLA
$1.29T
$4.27M 0.07%
+153,210
New +$3.32M
MRTX
158
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$4.06M 0.07%
31,500
-25,000
-44% -$2.41M
AYX
159
DELISTED
Alteryx Inc
AYX
$4M 0.07%
+40,000
New +$4.07M
MYOK
160
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$3.86M 0.07%
53,000
ARWR icon
161
Arrowhead Research
ARWR
$12.3B
$3.43M 0.06%
+54,120
New +$2.69M
MRAM icon
162
Everspin Technologies
MRAM
$415M
$3.42M 0.06%
650,691
+691
+0.1% +$3.78K
GH icon
163
Guardant Health
GH
$22.2B
$3.36M 0.06%
43,000
+10,000
+30% +$721K
ARNA
164
DELISTED
Arena Pharmaceuticals Inc
ARNA
$3.18M 0.06%
70,000
ZGNX
165
DELISTED
Zogenix, Inc.
ZGNX
$3.13M 0.05%
+60,000
New +$2.75M
REED
166
DELISTED
Reeds, Inc. Common Stock
REED
$3.07M 0.05%
67,500
+31,500
+88% +$1.22M
RETA
167
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$3.07M 0.05%
+15,000
New +$2.74M
WB icon
168
Weibo
WB
$1.91B
$3.04M 0.05%
65,648
-9,000
-12% -$421K
NSSC icon
169
Napco Security Technologies
NSSC
$1.39B
$2.94M 0.05%
200,000
+80,000
+67% +$1.16M
KYNB
170
Kyntra Bio
KYNB
$28.7M
$2.83M 0.05%
2,640
-5,200
-66% -$5.31M
SRPT icon
171
Sarepta Therapeutics
SRPT
$1.94B
$2.77M 0.05%
21,500
GTES icon
172
Gates Industrial Corporation Ltd.
GTES
$7.05B
$2.71M 0.05%
196,731
+28,329
+17% +$323K
AGIO icon
173
Agios Pharmaceuticals
AGIO
$2.04B
$2.67M 0.05%
56,000
-100,000
-64% -$3.78M
HDB icon
174
HDFC Bank
HDB
$119B
$2.57M 0.04%
+81,120
New +$2.47M
ZTO icon
175
ZTO Express
ZTO
$17.6B
$2.1M 0.04%
90,000

Similar funds

Handelsbanken Fonder's Q4 2019 Portfolio in Review

As of Q4 2019, Handelsbanken Fonder held 195 positions worth $5.78B, up 17% from $4.95B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Handelsbanken Fonder deployed $277M of net new capital in Q4 2019, opening 15 new positions and adding to 119 existing holdings. Its largest new stake was Darling Ingredients: 1,396,356 shares worth $39.2M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Welbilt, Inc., an estimated $19.1M trimmed.

  • Handelsbanken Fonder's largest Q4 2019 buy was Darling Ingredients: 1,396,356 shares worth $39.2M.
  • Handelsbanken Fonder added most to Service Corp International in Q4 2019, an estimated $17.3M increase.
  • Handelsbanken Fonder's biggest Q4 2019 reduction was Welbilt, Inc., cutting an estimated $19.1M.
  • Handelsbanken Fonder fully exited Cisco in Q4 2019, selling an estimated $20.6M.
  • Handelsbanken Fonder's ten largest holdings make up 27% of its $5.78B portfolio in Q4 2019.
  • Handelsbanken Fonder opened 15 new positions and closed 13 in Q4 2019.
  • Handelsbanken Fonder's portfolio value rose 17% quarter-over-quarter to $5.78B.

Based on Handelsbanken Fonder's 13F filing for Q4 2019, filed 14 Feb 2020.